-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ErFPrZkMo9hsYY/dROzJap9mfyxNE360vHJwf0Xw5d/T9cetCuf+UMm5edqU2sM/ l7zjm8f79KkO//vige5IPQ== 0001441844-10-000053.txt : 20100706 0001441844-10-000053.hdr.sgml : 20100705 20100706141728 ACCESSION NUMBER: 0001441844-10-000053 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100701 FILED AS OF DATE: 20100706 DATE AS OF CHANGE: 20100706 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ISRAEL ROBERT J CENTRAL INDEX KEY: 0001250274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 10938508 MAIL ADDRESS: STREET 1: 50 OXFORD DR CITY: MONTEBELLE STATE: NY ZIP: 10901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 edgardoc.xml PRIMARY DOCUMENT X0303 4 2010-07-01 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001250274 ISRAEL ROBERT J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 Sr. VP, Medical Affairs Common Stock 2010-07-01 4 M 0 3590 4.44 A 35015 D Common Stock 2010-07-01 4 F 0 3223 5.35 D 31792 D Common Stock 2010-07-01 4 A 0 10000 0 A 41792 D ESPP (right to buy) 4.44 2010-07-01 4 M 0 3590 0 D 2010-07-01 2010-07-01 Common Stock 3590 0 D ESPP (right to buy) 5.48 2010-07-01 4 A 0 3070 0 A 2011-01-01 2011-01-01 Common Stock 3070 3070 D Non-Qualified Stock Option (right to buy) 5.35 2010-07-01 4 A 0 30000 0 A 2011-07-01 2020-07-01 Common Stock 30000 30000 D Acquired upon the complete exercise of a grant under the Non-Qualified Employee Stock Purchase Plan, which grant was previously reported at the start of a six month option term, to acquire common stock up to an option amount which is 25% of the optionee's quarterly salary less $6,250, at a purchase price equal to the lower of 100% of the market value on the date of grant or 85% of the market value on the date of exercise. Includes shares of common stock acquired from the non-reportable exercise under a Qualified Employee Stock Purchase Plan. Restricted Stock shall vest in three equal installments, commencing June 20, 2010. Granted under the Company's Non-Qualified Employeee Stock Purchase Plan. The option was granted on the first day of the option term and previously reported as a right to purchase shares of the Company's common stock at an exercise price equal to the market value on the date of grant. In accordance with the Non-Qualified Employee Stock Purchase Plan, the option is ultimately exercisable for an exercise price which is the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The number of shares exercised is based on the option amount divided by the lower of 100% of the market value on the grant date or 85% of the market value on the day prior to the exercise date. The option will be exercisable for that number of shares equal to the option amount (25% of the optionee's quarterly salary less $6,250) divided by the lesser of the market value of the common stock on the grant date or 85% of the market value on the day prior to the exercise date. The stock options become exercisable in three equal installments, commencing one year from the grant date. By: Robert A. Mckinney For: Robert J. Israel 2010-07-02 -----END PRIVACY-ENHANCED MESSAGE-----